Form 4: Teradyne CEO Gregory Smith Trades Shares

Teradyne, Inc. President and CEO Gregory Stephen Smith reported transactions involving company stock, including the acquisition of shares under a 10b5-1 plan and the exercise of stock options.

Summary

• Gregory Stephen Smith, President and CEO of Teradyne, Inc., reported stock transactions on May 15, 2026.
• These transactions were executed under a pre-arranged sales plan (Rule 10b5-1) adopted on February 12, 2026.
• Smith acquired 4,597 shares of common stock at a price of $72.10 per share.
• He also disposed of 8,597 shares of common stock at a price of $338.98 per share.
• Following these transactions, Smith beneficially owns 124,469.5729 shares of common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant sale of shares by the CEO, even though it was conducted under a 10b5-1 plan. The acquisition at a lower price is a minor positive offset.

Positives

• The transactions were conducted under a Rule 10b5-1 plan, indicating adherence to pre-determined trading strategies designed to avoid insider trading concerns.
• The acquisition of shares at a lower price point ($72.10) could be viewed positively if the stock price subsequently increases.

Negatives

• The disposal of a significant number of shares (8,597) at a higher price ($338.98) by the CEO might be interpreted as a signal of reduced confidence in future price appreciation, despite being part of a planned sale.

Risks

• The disposal of shares by a key executive could be perceived negatively by the market, potentially impacting investor sentiment.
• While executed under a 10b5-1 plan, the sheer volume of shares sold by the CEO might raise questions about his personal conviction in the company's short-term prospects.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. The transactions are based on a pre-established plan.

Management Comments

• The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 12, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
• This option was granted under the Issuer's 2006 Equity and Cash Compensation Incentive Plan, and became exercisable at the rate of 25% per year beginning on January 24, 2021, the first anniversary of the grant.

Industry Context

StockSavvy.ai notes that insider trading reports like Form 4 filings are crucial for understanding executive sentiment. While the use of a 10b5-1 plan mitigates concerns about opportunistic trading, significant sales by top executives can still influence market perception, especially in the semiconductor testing and industrial automation sectors where Teradyne operates.

Stakeholder Impact

• Shareholders: May interpret the CEO's sale of shares as a bearish signal, potentially impacting stock price, despite the 10b5-1 plan.
• Employees: May be influenced by the CEO's trading activity in their perception of the company's future prospects.
• Management: The transactions are part of a planned strategy, indicating adherence to governance protocols.

Next Steps

• Monitor future Form 4 filings for any further transactions by Gregory Stephen Smith or other Teradyne executives.
• Observe the market reaction to these reported transactions.

Key Dates

Recommendation

The filing reports routine insider transactions under a 10b5-1 plan. While the CEO's sale of a significant number of shares could be a minor concern, the adherence to a pre-established plan mitigates the risk of opportunistic trading. The acquisition of shares at a lower price is a positive counterpoint. Without further financial performance data or strategic updates, a 'hold' recommendation is prudent, suggesting investors await more substantive information before making significant decisions.

Keywords

Teradyne, TER, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Gregory Stephen Smith, Beneficial Ownership, Securities Exchange Act